Diabetes Devices and Drugs: North America Guides Global Market at a 5.9% Cagr from 2013 to 2019

Transparency Market

Research

Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis,

Size, Share, Growth, Trends and Forecast 2013 - 2019

Published Date

01-July-2014

208 Page Report

Buy Now

Request Sample

Press Release

Diabetes Devices and Drugs: North America Guides Global Market

at a 5.9% CAGR from 2013 to 2019:Transparency Market

Research

Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

Diabetes Device And Drugs

Market

REPORT DESCRIPTION

Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends

and Forecast 2013 - 2019

Diabetes is a chronic metabolic disease wherein the body is either not able to produce insulin (type-1) or is not able to

utilize the generated insulin (type-2). This elevated sugar level leads to various symptoms such as increased thirst, weight

loss, high appetite, frequent and sweet smelled urination. If untreated, diabetes causes various acute and chronic lifethreatening complications. This report studies the current as well as future scenario of the diabetes diagnostic devices and

drugs market globally.

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/diabetes-devices-market.html

The diabetes diagnostic devices and drugs market has been segmented based on devices and drugs available for the

treatment the disease. Based on device type, the market is segmented into diabetes diagnostic devices and insulin

delivery devices. Diabetes diagnostic devices include analog blood meter, test strips, lancets and lancing devices,

continuous glucose monitoring devices and others. The insulin delivery devices segment include insulin syringes, insulin

pens, insulin pumps and insulin injectors.

Based on drugs, the market is segmented into insulin derivatives, oral anti-diabetes drugs...